CTSO CytoSorbents Corporation

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

 

 

Under the Securities Exchange Act of 1934

 

(Amendment No. )*

 

 

CytoSorbents Corporation

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

23283X206

(CUSIP Number)

 

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

/x/       Rule 13d-1(b)

 

/ /       Rule 13d-1(c)

 

/ /       Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP NO. 23283X206

13G

 

1

NAMES OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

Skylands Capital, LLC

20-0775613

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)

(b)

 

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

Wisconsin

 

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5 SOLE VOTING POWER

3,159,213

 

6 SHARED VOTING POWER

0

 

7 SOLE DISPOSITIVE POWER

3,254,213

 

8 SHARED DISPOSITIVE POWER

0

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,254,213

 

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

 

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

7.3%

 

12

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

IA

 

 

CUSIP NO. 23283X206

13G

 

 

ITEM 1 (a)

NAME OF ISSUER

CytoSorbents Corporation

 

ITEM 1 (b)

ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES

305 College Road East

Princeton, NJ 08540

 

ITEM 2 (a)

NAME OF PERSON FILING

Skylands Capital, LLC

 

ITEM 2 (b)

ADDRESS OF PRINCIPAL OFFICE OR, IF NONE, RESIDENCE

1200 N Mayfair Rd, Suite 250

Milwaukee, WI 53226

 

ITEM 2 (c)

CITIZENSHIP

Wisconsin Limited Liability Company

 

ITEM 2 (d)

TITLE OF CLASS OF SECURITIES

Common stock

 

ITEM 2 (e)

CUSIP NUMBER

23283X206

 

ITEM 3

THIS STATEMENT IS FILED PURSUANT TO PARAGRAPH 240.13d-1(b) AND

THE PERSON FILING IS:

(e) an investment advisor in accordance with paragraph 240.13d-1(b)(1)(ii)(E)

 

ITEM 4                  OWNERSHIP:

 

ITEM 4 (a)

AMOUNT BENEFICIALLY OWNED:

3,254,213

 

ITEM 4 (b)

PERCENT OF CLASS:

7.3%

 

ITEM 4 (c)

NUMBER OF SHARES AS TO WHICH THE PERSON HAS:

 

(i)

SOLE POWER TO VOTE OR TO DIRECT THE VOTE

3,159,213

 

(ii)

SHARED POWER TO VOTE OR TO DIRECT THE VOTE

0

 

(iii)

SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

3,254,213

 

(iv)

SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

0

 

ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

This statement is being filed to report the fact that as of the date hereof the reporting person continues to be the beneficial owner of more than 5 percent of the class of securities.

.

 

 

CUSIP NO. 23283X206

13G

 

ITEM 6

OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

N/A

 

ITEM 7

IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:

N/A

 

ITEM 8

IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

N/A

 

ITEM 9

NOTICE OF DISSOLUTION OF THE GROUP:

N/A

 

ITEM 10

CERTIFICATION:

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth

in this statement is true, complete and correct.

January 8, 2024

Date

 

BY: Virginia E. Shaffar

Signature

 

Vice President & Treasurer

Skylands Capital, LLC

Title

 

 

---